Malafaya Patrícia B, Stappers Frank, Reis Rui L
3B's Research Group--Biomaterials, Biodegradable and Biomimetics, Department of Polymer Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
J Mater Sci Mater Med. 2006 Apr;17(4):371-7. doi: 10.1007/s10856-006-8240-z.
This paper describes the development and characterization of starch microspheres for being used as drug delivery carriers in tissue engineering applications. The developed starch microspheres can be further loaded with specific growth factors and immobilized in scaffolds, or administrated separately with scaffolds. Furthermore and due to the processing conditions used, it is expected that these microspheres can be also used to encapsulate living cells. The aim of this study was to evaluate the efficacy of this methodology for further studies with biologically active agents or living cells. The starch microspheres were prepared using an emulsion crosslinking technique at room temperature to allow for the loading of biologically active agents. A preliminary study was performed to evaluate the incorporation of a model drug (nonsteroidal anti-inflammatory drug-NSAID) and investigate its release profile as function of changes in the medium parameters, such as ionic strength and pH. The developed starch-based drug delivery system has shown to be dependent on the ionic strength of the release medium. From preliminary results, the release seems to be pH-dependent due to the drug solubility. It was found that the developed microspheres and the respective processing route are appropriate for further studies. In fact, and based in the processing conditions and characterization, the developed system present a potential for the loading of different growth factors or even living cells on future studies with these systems for improving bone regeneration in tissue engineering, especially because the crosslinking reaction of the microspheres takes place at room temperature.
本文描述了淀粉微球作为组织工程应用中药物递送载体的开发与表征。所开发的淀粉微球可进一步负载特定生长因子并固定在支架中,或与支架分开给药。此外,由于所采用的加工条件,预计这些微球还可用于封装活细胞。本研究的目的是评估该方法在进一步研究生物活性剂或活细胞方面的有效性。淀粉微球采用乳液交联技术在室温下制备,以便负载生物活性剂。进行了一项初步研究,以评估模型药物(非甾体抗炎药 - NSAID)的掺入情况,并研究其作为介质参数(如离子强度和pH值)变化的函数的释放曲线。所开发的基于淀粉的药物递送系统已显示出依赖于释放介质的离子强度。从初步结果来看,由于药物溶解度,释放似乎依赖于pH值。发现所开发的微球及其各自的加工路线适合进一步研究。事实上,基于加工条件和表征,所开发的系统在未来使用这些系统改善组织工程中骨再生的研究中具有负载不同生长因子甚至活细胞的潜力,特别是因为微球的交联反应在室温下进行。